Debanjan Chakroborty
Overview
Explore the profile of Debanjan Chakroborty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Basu B, Chakroborty D, Sarkar C
Front Cell Dev Biol
. 2025 Feb;
13:1542429.
PMID: 40008101
No abstract available.
2.
Kakkat S, Suman P, Turbat-Herrera E, Singh S, Chakroborty D, Sarkar C
Front Cell Dev Biol
. 2024 Jul;
12():1408844.
PMID: 39040042
Obesity is a multifaceted metabolic disorder characterized by excessive accumulation of adipose tissue. It is a well-established risk factor for the development and progression of breast cancer. Adipose tissue, which...
3.
Chakroborty D, Singh A
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38473699
Prostate cancer (PCa) is the second most common cancer and the fifth highest cause of cancer-related death among men in the world [...].
4.
Kakkat S, Pramanik P, Singh S, Singh A, Sarkar C, Chakroborty D
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108147
Cardiovascular diseases (CVDs) and complications are often seen in patients with prostate cancer (PCa) and affect their clinical management. Despite acceptable safety profiles and patient compliance, androgen deprivation therapy (ADT),...
5.
Goswami S, Sarkar C, Singh S, Singh A, Chakroborty D
Cancer Health Disparities
. 2023 Feb;
6.
PMID: 36777283
Disparities in cancer incidence and outcome are common among the racial and ethnical minorities in the United States and are of significant social and clinical concern. Prostate cancer is the...
6.
Chakroborty D, Goswami S, Fan H, Frankel W, Basu S, Sarkar C
Br J Cancer
. 2022 Jul;
127(8):1440-1449.
PMID: 35902640
Background: Resistance to anti-angiogenic therapies targeting vascular endothelial growth factor-A (VEGF-A) stems from VEGF-A independent angiogenesis mediated by other proangiogenic factors. Therefore identifying these factors in colon adenocarcinoma (CA) will...
7.
Sarkar C, Chakroborty D, Goswami S, Fan H, Mo X, Basu S
J Cell Sci
. 2022 May;
135(11).
PMID: 35593650
We have previously demonstrated significant upregulation of dopamine D2 (DAD2) receptor (DRD2) expression on tumor endothelial cells. The dopamine D2 receptors, upon activation, inhibit the proangiogenic actions of vascular endothelial...
8.
Chakroborty D, Goswami S, Basu S, Sarkar C
FASEB J
. 2020 Sep;
34(11):14093-14102.
PMID: 32949437
Angiogenesis involves the formation of new blood vessels from preexisting ones, and it is an essential step during cutaneous wound healing, which supports cells at the wound site with nutrition...
9.
Sarkar C, Goswami S, Basu S, Chakroborty D
Cancers (Basel)
. 2020 Aug;
12(9).
PMID: 32842503
Prostate cancer (PCa), like all other solid tumors, relies on angiogenesis for growth, progression, and the dissemination of tumor cells to other parts of the body. Despite data from in...
10.
Sarkar C, Ganju R, Pompili V, Chakroborty D
Angiogenesis
. 2016 Nov;
20(1):97-107.
PMID: 27853962
Increased circulating catecholamines have been linked with cardiovascular anomalies as well as with peripheral vascular diseases. Although the roles of epinephrine and norepinephrine have received considerable attention, the role of...